Upcoming Meetings
-
Meetings and News
- Gynion & IdleSmart June 14, 2022
- Bloom for All & OrderTaker Solutions May 12, 2022
- Pointz Mobility & The Family Learning Company April 12, 2022
- Contacts411 & Connective Health March 8, 2022
- TopProp Fantasy & Encapsulate February 8, 2022
- Jaia Robotics & Imago Rehab December 14, 2021
Archives
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- December 2021
- November 2021
- October 2021
- September 2021
- July 2021
- June 2021
- May 2021
- April 2021
- February 2021
- January 2021
- December 2020
- September 2020
- December 2019
- June 2019
- December 2018
- December 2017
- December 2016
- August 2016
- December 2015
- October 2015
- December 2014
- December 2013
- December 2012
- December 2011
- December 2010
Network
The Angel Treaty
Blog Stats
- 123,590 hits
-
Join 209 other subscribers
Author Archives: Angel Treaty
Gynion & IdleSmart
At its meeting the morning of Flag Day 2022, Beacon Angels members considered funding proposals from the following companies: Mr. Oleg Shikhman, CEO, Gynion—developing MenorrxTM treatment for Heavy Menstrual Bleeding (HMB), Menorrx is a safe and effective endometrial ablation therapy … Continue reading
Bloom for All & OrderTaker Solutions
At the Beacon Angels meeting held on Tuesday, May 12, 2022, we entertained funding proposals from the following new company presenters: BloomForAll (Joanne Mercaldi & Team), offering teenagers a safe, inclusive and mindful health information platform powered by doctors, educators, … Continue reading
Posted in Uncategorized
Leave a comment
Pointz Mobility & The Family Learning Company
At the Beacon Angels meeting held on April 12, 2022, we entertained new funding proposals from the following: Pointz Mobility, a safety-focused mapping app that leverages crowdsourcing to help guide bike and scooter riders through pleasant, lower-stress routes in cities; … Continue reading
Contacts411 & Connective Health
At the Beacon Angels meeting on March 8, 2022, we entertained funding proposals from the following: Ryan Hess, of Contacts411, which provides contact data enhancement and updating for very small businesses; and Karen Sallick, of Connective Health, providing a SAAS … Continue reading
TopProp Fantasy & Encapsulate
At the Beacon meeting held on February 8, 2022, members entertained new company funding proposals from the following: TopProp Fantasy, offering a daily fantasy sports platform that simplifies DFS down to its core: single-player fantasy; and Encapsulate, which is develops … Continue reading
Jaia Robotics & Imago Rehab
In another hybrid meeting held on December 14, 2022, Beacon Angels members heard the following new company funding proposals: Jaia Robotics, developing “JaiaBots,” low cost, high speed, micro-sized autonomous aquatic robots that work in pods of up to 20 to … Continue reading
Lightwater Biosciences & Shoreline Biome
At its monthly breakfast meeting on November 9, 2021, Beacon members met in person and remotely, where we heard new company funding proposals as follows: Lightwater Biosciences (speaking in person: CEO Soo-Young Kang & Bill McCullen of Launch Capital) offering … Continue reading
Embrace Prevention Care & NF2 Therapeutics At its meeting on the morning of Tuesday, October 12, 2021, Beacon Angels members entertained new company funding proposals as follows: Embrace Prevention Care (speaking in person, David Dlesk, CEO), which provides Personal Prevention … Continue reading
Phimentum, Reeske & Dermal Photonics
At its meeting on the morning of September 14, 2021, Beacon Angels members entertained funding proposals from: Phimentum, which supplies a novel form of therapeutic braces to general dentists, enabling them to generate high profits while lowering patient costs and geographic barriers; and … Continue reading
Posted in Uncategorized
Leave a comment
VeraMorph & Dyad Medical
At our monthly breakfast meeting on January 11, 2022, Beacon Angels met in person and remotely to hear the following new company funding presentations: VeraMorph: reformulating generic drugs to be more efficacious orally and co-developing new drugs through partnerships as … Continue reading